Weight Loss Therapeutics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2018-2029)
2.2 Weight Loss Therapeutics Growth Trends by Region
2.2.1 Weight Loss Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Weight Loss Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Weight Loss Therapeutics Market Dynamics
2.3.1 Weight Loss Therapeutics Industry Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Weight Loss Therapeutics Players by Revenue
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2022
3.5 Weight Loss Therapeutics Key Players Head office and Area Served
3.6 Key Players Weight Loss Therapeutics Product Solution and Service
3.7 Date of Enter into Weight Loss Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2029)
5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Weight Loss Therapeutics Market Size (2018-2029)
6.2 North America Weight Loss Therapeutics Market Size by Country (2018-2023)
6.3 North America Weight Loss Therapeutics Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2018-2029)
7.2 Europe Weight Loss Therapeutics Market Size by Country (2018-2023)
7.3 Europe Weight Loss Therapeutics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Weight Loss Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size (2018-2029)
9.2 Latin America Weight Loss Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Weight Loss Therapeutics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Detail
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2018-2023)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Detail
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2018-2023)
11.5.5 Orexigen Therapeutics Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Biocon
11.9.1 Biocon Company Detail
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2018-2023)
11.9.5 Biocon Recent Development
11.10 VIVUS
11.10.1 VIVUS Company Detail
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2018-2023)
11.10.5 VIVUS Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2018-2023)
11.11.5 Eli Lilly Recent Development
11.12 Amgen
11.12.1 Amgen Company Detail
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.12.5 Amgen Recent Development
11.13 Zafgen
11.13.1 Zafgen Company Detail
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.13.5 Zafgen Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2018-2023)
11.14.5 Roche Recent Development
11.15 Eisai
11.15.1 Eisai Company Detail
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2018-2023)
11.15.5 Eisai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Appetite Suppression
Table 3. Key Players of Increasing Body Metabolism
Table 4. Key Players of Interfering with the Digestion Absorption Patterns
Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Weight Loss Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Weight Loss Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Weight Loss Therapeutics Market Share by Region (2018-2023)
Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Weight Loss Therapeutics Market Share by Region (2024-2029)
Table 11. Weight Loss Therapeutics Market Trends
Table 12. Weight Loss Therapeutics Market Drivers
Table 13. Weight Loss Therapeutics Market Challenges
Table 14. Weight Loss Therapeutics Market Restraints
Table 15. Global Weight Loss Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2022)
Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Weight Loss Therapeutics Product Solution and Service
Table 22. Date of Enter into Weight Loss Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Weight Loss Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Weight Loss Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2024-2029)
Table 32. North America Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Weight Loss Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Weight Loss Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 38. Latin America Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Weight Loss Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Abbott Company Detail
Table 43. Abbott Business Overview
Table 44. Abbott Weight Loss Therapeutics Product
Table 45. Abbott Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 46. Abbott Recent Development
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Weight Loss Therapeutics Product
Table 50. Sanofi Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Novo Nordisk Company Detail
Table 53. Novo Nordisk Business Overview
Table 54. Novo Nordisk Weight Loss Therapeutics Product
Table 55. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Novo Nordisk Recent Development
Table 57. Arena Pharmaceuticals Company Detail
Table 58. Arena Pharmaceuticals Business Overview
Table 59. Arena Pharmaceuticals Weight Loss Therapeutics Product
Table 60. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Arena Pharmaceuticals Recent Development
Table 62. Orexigen Therapeutics Company Detail
Table 63. Orexigen Therapeutics Business Overview
Table 64. Orexigen Therapeutics Weight Loss Therapeutics Product
Table 65. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Orexigen Therapeutics Recent Development
Table 67. Johnson & Johnson Company Detail
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Weight Loss Therapeutics Product
Table 70. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Weight Loss Therapeutics Product
Table 75. Pfizer Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Novartis AG Company Detail
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Weight Loss Therapeutics Product
Table 80. Novartis AG Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. Biocon Company Detail
Table 83. Biocon Business Overview
Table 84. Biocon Weight Loss Therapeutics Product
Table 85. Biocon Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Biocon Recent Development
Table 87. VIVUS Company Detail
Table 88. VIVUS Business Overview
Table 89. VIVUS Weight Loss Therapeutics Product
Table 90. VIVUS Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 91. VIVUS Recent Development
Table 92. Eli Lilly Company Detail
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Weight Loss TherapeuticsProduct
Table 95. Eli Lilly Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 96. Eli Lilly Recent Development
Table 97. Amgen Company Detail
Table 98. Amgen Business Overview
Table 99. Amgen Weight Loss TherapeuticsProduct
Table 100. Amgen Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 101. Amgen Recent Development
Table 102. Zafgen Company Detail
Table 103. Zafgen Business Overview
Table 104. Zafgen Weight Loss TherapeuticsProduct
Table 105. Zafgen Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 106. Zafgen Recent Development
Table 107. Roche Company Detail
Table 108. Roche Business Overview
Table 109. Roche Weight Loss TherapeuticsProduct
Table 110. Roche Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 111. Roche Recent Development
Table 112. Eisai Company Detail
Table 113. Eisai Business Overview
Table 114. Eisai Weight Loss TherapeuticsProduct
Table 115. Eisai Revenue in Weight Loss Therapeutics Business (2018-2023) & (US$ Million)
Table 116. Eisai Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2022 VS 2029
Figure 2. Appetite Suppression Features
Figure 3. Increasing Body Metabolism Features
Figure 4. Interfering with the Digestion Absorption Patterns Features
Figure 5. Global Weight Loss Therapeutics Market Share by Application in 2022 & 2029
Figure 6. Hospitals Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Weight Loss Therapeutics Report Years Considered
Figure 12. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Weight Loss Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Weight Loss Therapeutics Market Share by Region: 2022 VS 2029
Figure 15. Global Weight Loss Therapeutics Market Share by Players in 2022
Figure 16. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2022
Figure 18. North America Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Weight Loss Therapeutics Market Share by Country (2018-2029)
Figure 20. United States Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Weight Loss Therapeutics Market Share by Country (2018-2029)
Figure 24. Germany Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2018-2029)
Figure 32. China Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Weight Loss Therapeutics Market Share by Country (2018-2029)
Figure 40. Mexico Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2018-2029)
Figure 44. Turkey Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 48. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 49. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 50. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 51. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 53. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 54. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 55. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 56. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 57. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 58. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 60. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
